The U.S. Food and Drug Administration approved a new prescription-strength pain reliever from Vertex Pharmaceuticals on Jan. 30, 2025. Journavx is a non-opioid drug that prevents peripheral nerves ...
UnitedHealthcare likely to cover Vertex’s pain drug Vertex Pharmaceuticals received FDA approval for a new non-opioid pain drug, marketed as Journavx, and it appears the nation’s largest ...
Petroleo Brasileiro S/A Ord-1.25% R$510.15B Petroleo Brasileiro S/A Pref-0.64% R$510.15B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback